Finance
Medical
Sports
Organogenesis
$6.979876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$6.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.02 (-0.29%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Organogenesis and other stocks, options, ETFs, and crypto commission-free!
About
Organogenesis Holdings Inc. Class A Common Stock, also called Organogenesis, is a regenerative medical company. Read More It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
Employees
700
Headquarters
Canton, Massachusetts
Founded
1985
Market Cap
636.47M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
79.04K
High Today
$7.17
Low Today
$6.77
Open Price
$6.95
Volume
18.77K
52 Week High
$310.90
52 Week Low
$6.28
Collections
Finance
Medical
Sports
Health
Entertainment
2016 IPO
US
North America
News
Yahoo FinanceMay 10
Organogenesis Holdings Inc. Reports First Quarter 2019 Financial Results
CANTON, Mass., May 10, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for its first quarter ended March 31, 2019. First Quarter 2019 Financial Summary : Net revenue of $57.1 million for the first quarter of 2019, up 60.8% compared to net revenue of $35.5 million for the ...
Price Paid on Robinhood
33% Lower
Right Now
52 Week Low
$6.28
Average Price Paid
$10.36
52 Week High
$310.90
Earnings
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Available May 10, Pre-Market